Cintas (NASDAQ:CTAS) PT Raised to $362.00 at Morgan Stanley
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Stay updated with breaking news from Target Advisor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
HCA Healthcare (NYSE:HCA – Get Rating) had its price target lowered by SVB Leerink from $273.00 to $212.00 in a research report issued on Friday, Stock Target Advisor reports. The firm presently has an “outperform” rating on the stock. SVB Leerink’s target price would suggest a potential upside of 23.54% from the stock’s previous close. […]
Insmed (NASDAQ:INSM – Get Rating) had its price objective cut by equities research analysts at Morgan Stanley from $46.00 to $41.00 in a research report issued on Friday, Stock Target Advisor reports. The firm presently has an “overweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s target price suggests a potential upside of 77.26% from […]
Visteon (NYSE:VC – Get Rating) had its target price decreased by stock analysts at Morgan Stanley from $93.00 to $91.00 in a research note issued to investors on Thursday, Stock Target Advisor reports. Morgan Stanley’s price objective would suggest a potential downside of 15.66% from the stock’s current price. Separately, StockNews.com started coverage on shares […]